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ABSTRACT 
Introduction: While alpha-GPC (A-GPC) has received recent praise as a mental and 
physical performance enhancement supplement, very limited research on this topic 
exist, and no current studies examine A-GPC in collegiate-aged trained individuals. This 
study hopes to bridge the gap in the current research literature on the topic of A-GPC 
ingestion in young healthy adults in the cognitive and anaerobic paradigms. 
Purpose: To investigate and identify the acute effects of A-GPC ingestion on 
performance testing (hand-grip strength, jump height, power output/rate of force 
development, mood, & reaction time) of college-aged recreationally trained individuals. 
Methods: This study utilized a random, double-blinded, cross over design in which 27 
participants (m=15; f=12) ingested either the placebo (dextrose, Group 1) A-GPC (6 
mg·kgˉ¹ body mass, Group 2). Baseline measurements were obtained on the initial visit. 
On supplemental visits, immediately following ingestion, subjects were required to sit in 
a rested state for 25-minutes. Subjects first completed the 4-item mood questionnaire 
to assess subjective feelings of energy, fatigue, alertness and focus for tasking, followed 
by the pre reaction-time (RT) test. Body composition was then measured via the Bod 
Pod, followed by a standardized questionnaire indicating age and training experience. 
Each test consisted of four stations assessing physical task performance. Subjects 
participated on three different occasions separated by 2-14 days.  
Hypotheses: The author of this investigation predicted A-GPC would have a positive 
impact on the performance variables, improving power output and neurological 
stimulation. Furthermore, this study aimed to support preliminary evidence of the 
ergogenic properties in A-GPC  
Results: Twenty-seven total subjects participated in this study (Age: mean 21.66 ±SD 
1.88 years; Height: mean 68.4 ±SD 4.1 inches; Weight: mean 169. 02 ±SD 32.2 lbs.; Body 
fat: mean 19.2 ±SD 8.8%; Heart rate: mean 67.96 ±SD 8.2 beats/minute; SBP: 
120.59±SD12.39 mmHg; DBP 74.74±SD 9.12 mmHg). There were no significant 
differences between any of the variables pre to post testing. There were also no 
differences between males and females for any test variable. Repeated measures 
ANOVA: Multiple comparisons, LSD reveal statistical significances were found for the 
following the dependent variables (fatigue, plyometric push-up, mood change, and 
reaction-time test). Participants reported lower levels of fatigue following A-GPC 
ingestion, yielding a significance of (p=0.019) when compared to baseline. The A-GPC 
group showed increased levels of peak force production during the plyometric push-up 
when compared to placebo with significance of (p=0.014). Mood change increased with 
A-GPC ingestion compared to placebo with significance of (p=0.023); and subjects 
scored more accurate (less incorrect answers) during the reaction-time test post A-GPC 
ingestion compared to placebo (p=0.014). 
Discussion: A-GPC supplementation showed a 12% increase in upper body power 
output, and 12% improvement in accuracy during the reaction-time test. This 
investigation supports A-GPC as an ergogenic aid for physical or cognitive stimulation.
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CHAPTER I 
INTRODUCTION 
 
Alpha-GPC 
Alpha-glyceryl-phosphoryl-choline (A-GPC) supplementation has been shown to 
improve mental and physical performance (Parker et al., 2015), increasing mood and 
potentially power-output. While literature looks promising, only one pilot study exists 
examining the acute effects of power-output (Ziegenfuss et al., 2008), with the 
majority of literature on A-GPC being experimented on elderly persons and rodents. 
Therefore, more research in young healthy adults is needed to support A-GPC as an 
ergogenic aid (allowing the person to train with greater intensity for longer durations), 
possibly increasing force production.  
A-GPC is a choline containing phospholipid (Tayebati et al., 2013), an 
intermediary of lecithin breakdown or simply lecithin molecule with two less fatty 
acids (Zeisel, 1981). The supplement A-GPC is found as a naturally occurring 
constituent of red meat products (Armah et al., 2008) and organ tissue (Schmidt et al., 
1945). However, it can be challenging to consume effective amounts in naturally 
occurring sources (Zhang et al., 2012) therefore, it can be difficult to obtain enough A-
GPC in an individual’s diet to be beneficial, hence, supplementation may be necessary. 
A-GPC is organically created from egg (Brockerhoff & Yurkoski, 1965) or soy lecithin 
(Brownawell et al., 2011). When controlling the amount of choline in each supplement, 
A-GPC requires 46% the dose of CDP-Choline (also known as citicoline) (Tayebati et al., 
2 
2013). A-GPC revealed to be more effective, when tested by potency on a weight basis, 
as a cholinergic, than both choline and CDP-choline when looking at serum values or 
benefits from clinical research (Parnetti et al., 2007; Di Perri et al., 1991).  
Evidence supports citicoline and choline as positively impacting cognitive 
function, but little is known about either supplement’s impact on physical function. 
The literature does contain some evidence that choline itself is vital to consider in 
respect to endurance performance (Conlay et al., 1986; Penry & Manore et al., 2008) 
revealing evidence of aerobic ergogenic properties in choline. One study reported that 
a multi-ingredient supplement containing A-GPC improved mean power during 
maximal effort sprint testing on a non-motorized treadmill (Jajim et al., 2015), 
illustrating anaerobic properties in A-GPC as an ergogenic aid. However, common 
performance tasks such as vertical jump and hand-grip strength (often used to assess 
physical function ability in both athletic and non-athletic individuals) have not been 
investigated. 
Theoretically, with A-GPC being a more potent form of choline than citicoline, it 
would be logical to assume the supplement would serve as a more effective additive to 
physical performance efforts. Although A-GPC has been receiving recent praise as a 
performance enhancing supplement for some physical (Stoppani, 2010; Bellar et al., 
2015; Ziegenfuss et al., 2008) and neurological aspects of human function (Scapicchio, 
2013; Tomassoni et al., 2006), more research in human subjects on this topic is 
needed. 
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Of concern is that there is conflicting information in the literature regarding the 
effects of A-GPC.  For example, previous literature found that 30 minutes prior to 
testing, A-GPC supplementation (4 mg·kgˉ¹) had no significant beneficial effect on 
mood, cognitive function, and physiological performance (Parker et al., 2015). 
Conversely, one study presented at the 2008 Annual Meeting Of The International 
Society Of Sports Nutrition reported that trained men taking (6 mg·kgˉ¹) A-GPC 90-
minutes before workouts increased growth hormone (GH) levels by about 100% more 
than placebo (Stoppani, 2010). The lone pilot study on power output found evidence, 
that supplemental ingestion of A-GPC, given (6 mg·kgˉ¹) prior to a power test (bench 
throws), reported a 14% power output improvement relative to a placebo when taken 
45-minutes prior to activity (Ziegenfuss et al., 2008). These findings revealed 
supplementation also increased post-exercise serum GH. In contrast, supplementation 
showed no significant beneficial effect on peak power, rate of force development, 
RMR, or cardiovascular hemodynamics, such as heart rate and blood pressure. 
However, one study revealed A-GPC supplementation may augment lower body force 
production. These findings reveal a 3% increase in lower body isometric strength, 
following 6 days of acute A-GPC supplementation (Bellar et al., 2015). This contrast in 
results supports the need for further investigations into A-GPC and its impact on 
physiological performance.  
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Summary and Objectives 
Previous claims support the idea that A-GPC as a supplement can boost 
physical and mental performance; however, there is a gap in literature, noting only a 
hand full of research exist on this topic in human subjects. Therefore, this study aims 
to fill this gap in the literature, in regard to A-GPC as a power output and cognitive 
supplement in young healthy adults. The purpose of this investigation was to identify 
the acute effects of A-GPC in testing to placebo ingestion on jump height, hand-grip 
strength, rate of force development, power output, mood change, and reaction time in 
recreationally (moderately) trained, college-aged athletes. The author of this 
investigation predicts A-GPC ingestion will improve physical task performance on jump 
height, hand-grip strength, rate of force development, power output, mood, and 
reaction time in moderately trained young healthy adults. Primarily, the author of this 
study believed ergogenic properties in the supplement A-GPC exist, beneficially 
influencing power output and enhanced brain function. 
 
Limitations 
Subjects were subjectively screened using questionnaires only. It’s possible a 
physical by an MD with blood work may have revealed differences within and between 
subjects possibly affecting the results. Not all performance tasks were utilized. It’s 
possible different power tests and/or different reaction tests could elicit different 
results.  It’s possible different age groups and/or sub-groups (athletes, non-athletes, 
pediatrics, geriatrics, etc.) could have responded differently. 
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Delimitations 
This investigation only examined participants (18-26y) because there is 
currently a large body of research in elderly persons and high number of college-aged 
individuals. Subjects received body composition opposed to underwater weighing 
because it is faster, and easier. The mood questionnaire assessed levels of energy, 
fatigue, alertness, and focus; used to determine an individual’s mood because it was 
easy and self-reported on a scale. Reaction time was measured to determine accuracy 
and speed of response-time because it was a simple and easy for use. Hand-grip 
strength was used via the hand-grip dynamometer, a good overall indicator of 
strength, and easy to use. Standing vertical jump was measured to determine jump 
height and peak force production via the jump mat over the VerTec for its accuracy 
and simplicity. The plyometric push-up was tested to measure peak force production 
where only one preliminary piece of literature has supported upper body power 
output following A-GPC ingestion. Therefore, this investigation aims to bridge this gap 
on the current literature with supportive evidence pertaining to power output. 
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CHAPTER II 
LITERATURE REVIEW 
 
Background 
Choline is a precursor required to produce acetylcholine (Parnetti et al., 2007). 
This is clinically valuable due to vast research suggesting learning, memory, 
intelligence, and mood are stimulated in part by acetylcholine metabolism in neural 
function (Hasselmo et al., 2006). L-alpha-glycerylphosphorylcholine (GPC) is a water-
soluble, natural choline compound, deacylated phosphocreatine(PC) derivative, which 
evidence supports effectiveness against the loss of membrane function in central 
nervous system(CNS) injuries (Amenta et al. 1994).  
 Sangiorgi and colleagues (1994) noted, “GPC is a precursor molecule of the 
neurotransmitter acetylcholine and was recently tested as a centrally acting 
parasympathic precursor molecule of the neurotransmitter acetylcholine” (p. 253-69), 
and evidence support it as a centrally acting parasympathominetic drug in dementia 
disorders and acute cardio vascular diseases (De Jesus Moreno Moreno 2003). GPC 
acts as a PC precursor and increases in uptake of membrane (Galazzini and Burg, 
2009). This increased uptake of membrane-forming phospholipids, and PC exerted an 
anti-inflammatory stimulation in previous investigational research (Chao et al, 1995, 
El-Hariri et al. 1992). Parnetti and colleagues (2007) noted, “The deacylated, water 
soluble PC analogue GPC rapidly delivers choline to the brain across the blood-brain-
barrier (BBB)” (264-69). Another study found that pre-treatment with GPC is protective 
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against CNS irradiation-induced peripheral effects (Tőkés et al., 2014). GPC is a choline 
donor compound where a recent experimental study revealed parasympathomimetic 
action (Gibellini & Smith, 2010). This parasymphatomimetic action illustrates its 
activation of the “rest and digest” division of the nervous system.  
A-GPC has been shown to increase the release of neurotransmitter of 
acetylcholine and facilitates learning and memory (Scapicchio, 2013). Another study 
found higher acetylcholine production allows A-GPC to boost GH response to 
weightlifting (Stoppani, 2010). One investigation observed the effects of A-GPC, 
caffeine or placebo on markers of mood, cognitive function, power, speed, and agility, 
where A-GPC prevented exercise-induced reductions in exhaustive levels (Parker et al., 
2015). The only current evidence supporting A-GPC supplementation as effective for 
nootropic purposes in young healthy adults (18-35y) found A-GPC (Alpha BRAIN®) 
ingestion improved recent verbal memory when compared to controls (Solomon et al., 
2016) as it appears to have cognitive improving properties. However, more research is 
needed because no current evidence in humans can be found in the literature. 
However, previous investigations supported A-GPC intake in rodents (Lopez et al., 
1991; Amenta et al., 2001; Trabucchi et al., 1986; Abbiati et al., 1993). More evidence 
supports A-GPC supplementation on neuroprotective properties for ischemia attack, or 
stroke patients (Zhang et al., 2013; Kidd et al., 2009). Other findings reveal A-GPC may 
decrease the rate of cognitive decline when consuming (1200mg) of A-GPC daily 
(Scapicchio, 2013; Tőke´s et al., 2015). Zhang and colleagues (2013) noted, “Plasma 
choline increased 30-130 minutes’ post-ingestion (spikes at 60 minutes)” (p. 96-103) 
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and returns to baseline at 4 hours (Kawamura et al., 2012) with A-GPC 
supplementation. A-GPC in Europe currently is being used as treatment of head 
trauma and other acute brain injuries in addition to stroke (Onishchenko et al., 2008). 
 
Primary Studies 
Preliminary evidence found A-GPC may be beneficial for power output, 
revealing a 14 % increase on bench throws in men with two years of training 
experience (Ziegenfuss et al., 2008), when consuming (6 mg·kgˉ¹) of A-GPC 45-minutes 
prior to exercise; this being the lone experimental study on power output following A-
GPC consumption. Although the ergogenic properties in A-GPC look promising, more 
research is required to validate this evidence.  
Stoppani (2010) found evidence that A-GPC consumption of (6 mg·kgˉ¹) 90-
minutes before exercise increased growth hormone levels by about 100% more than 
placebo. Another study revealed evidence that A-GPC ingestion enhances strength, 
particularly in the lower body after six days of administration when taking (6 mg·kgˉ¹) 
of A-GPC 60-minutes prior to physical activity (Bellar et al., 2015). Other literature also 
found when taking (6 mg·kgˉ¹) of A-GPC prior to physical activity that acute 
supplementation was shown to augment bench press in a small sample of men with 2 
years of training experience (Ziegenfuss et al., 2015). One study found (4 mg·kgˉ¹) of A-
GPC 30-minutes before exercise prevents exercise induced reductions in choline levels, 
increases endurance performance and GH secretion (Parker et al., 2015). (See Table 1 
for previous studies on acute supplementation of A-GPC). 
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The most recent study evaluating the effects of A-GPC on physical and 
psychomotor performance found A-GPC (2.5 mg·kgˉ¹) consumption prior to exercise 
improved maximal velocity and maximum mechanical power on counter movement 
jump (Marcus et al., 2017). Based on previous literature regarding A-GPC, it seems 
logical for the supplement to be at least considered as an emerging ergogenic aid. 
 
Table 1: Previous Studies on Alpha-GPC 
Investigator  Nutrient Timing  Findings 
Stoppani, 2010 (6 mg·kgˉ¹) 90-min Increased GH levels 100% 
more than placebo 
Ziegenfuss et al, 2008 (6 mg·kgˉ¹) 90-min Improved p-output 14% 
relative to placebo 
Bellar et al., 2015 (6 mg·kgˉ¹) 60-min Enhanced strength, 
particularly in lower body 
after 6-days of 
administration  
Parker et al., 2015 (4 mg·kgˉ¹) 30-min Prevents exercise induced 
reductions in choline 
levels, increases 
endurance performance, 
and growth hormone 
secretion 
Marcus et al., 2017 (2.5 mg·kgˉ¹) 120-min Improved maximal 
velocity and mechanical 
power on counter 
movement jump 
Hoffman et al., 2010 (1.5 mg·kgˉ¹) 10-min Prevent exercise-induced 
decline in subjective 
feelings of focus and 
alertness following 
exhaustive exercise 
 
Reaction time was maintained post-exhaustive exercise (Parker et al., 2015). A 
study by Parker and colleagues (2015) found “acute supplementation with A-GPC had 
no statistically significant beneficial effect on measures of mood, cognitive function, or 
physiological performance, in part due to large individual variability between subjects” 
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(p. 41). However, A-GPC seemed to improve physical and mental performance tasks. 
(See Figure 1 for a recent study on A-GPC and Caffeine). 
 
 
Figure 1: The effects of alpha-GPC-L (+8.5%), alpha-GPC-H (7.5%), and caffeine 
(+2.0%), in comparison to placebo, on vertical jump peak power (in watts) (Parker et 
al., 2015) 
 
Growth Hormone Response to A-GPC 
Ceda and company (1992) noted, “Growth hormone secretion in response to 
stimulation (via GHRH) is amplified with administration of A-GPC, and although it can 
be effective in both young and elderly it appears that elderly persons require a greater 
relative increase, due to having less output initially” (p. 119-21). A-GPC’s primary 
target is to augment the growth-hormone response to exercise, which can 
subsequently induce the release of the anabolic hormone insulin-like growth factor-1, 
which alone is enough to make A-GPC a valuable supplement (Barr, 2010). A-GPC 
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ingestion (3-6 mg·kgˉ¹) of may be beneficial for power output and act as an ergogenic 
aid (Ziegenfuss et al., 2008).  
Previous literature found A-GPC was able to maintain reaction time in humans 
following exhaustive exercise (Hoffman et al., 2010). One study illustrated A-GPC 
provided evidence for power output improvements following ingestion for upper body 
force production during bench throws (Ziegenfuss et al., 2008). Another study found 
increases in lower body strength but failed to find evidence for improved upper-body 
strength during isometric testing. A-GPC seems promising however; more evidence is 
required to validate the ergogenic effects of acute supplementation. A-GPC has shown 
to augment acetylcholine levels in neurons in rat CNS (Traini et al., 2013). More 
research needed to determine the neurological and physical properties of A-GPC in 
human subjects. No studies look at chronic hormone spikes from A-GPC 
supplementation. One study revealed A-GPC supplementation may augment lower 
body force production. These findings reveal a 3% increase in lower body isometric 
strength, following 6 days of acute A-GPC supplementation (Bellar et al., 2015). 
Therefore, athletic trainers and sport professionals may consider adding A-GPC to the 
diet of athletes to improve muscle performance. This investigation hopes to shed new 
light on these contradictive findings for upper body power output during the 
plyometric push-up. 
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Nutrient Interactions 
 Previously literature claim A-GPC may have a synergistic effect with caffeine 
(Bruce et al., 2014). Uridine may be effective in supplemental form to increase brain 
GPC concentrations (Agarwal et al., 2018), but contradictive findings reveal this may 
not be the case (Silveri et al., 2008). The current literature gives mixed evidence on the 
influence A-GPC has on interacting with iron. One study found A-GPC supplementation 
improved absorption of nonheme iron from food products comparable to that of 
vitamin C when given at 2:1 ratio (Armah et la., 2008). However, another study failed 
to find evidence supporting this theory when doubling the ratio to 4:1 (Troesch et al., 
2009).  
 
Performance Testing 
 Mood Questionnaire. The 4-item mood questionnaire was created to assess 
subjective feelings of energy, fatigue, alertness and focus for tasking (Hoffman et al., 
2010) consisting of a 10-point rating scale by verbal selection according to previously 
used methods. Specifically, subjects were asked to rate their response using verbal 
cues on a scale of a 1-10 which corresponded from 1= very low to 10 = very high. One 
previous study found acute ingestion of an A-GPC containing supplement can prevent 
the exercise-induced decline in subjective feelings of focus, and alertness in healthy 
college students following exhaustive exercise (Hoffman et al., 2010). Although 
cognitive influencing properties of A-GPC seem promising, more research is required 
to clarify these nootropic benefits. 
13 
Hand Grip Strength 
The purpose of this test was to measure the maximum isometric strength of 
the hand and forearm muscles and is a good overall indicator of strength. A handgrip 
dynamometer needed to perform this assessment. Currently there has been research 
examining the acute effects A-GPC supplementation has on hand-grip strength and this 
investigation is the first to look at these variables. (See Appendix A for figure). 
 
Standing Vertical Jump Test 
The purpose of this test was to assess average jump height and peak jump 
performance. Vertical jump was recorded using the Just Jump via force plates to 
examine rate of force development and peak force production. Previous literature 
found improvement during the counter movement jump following A-GPC ingestion 
(Marcus et al., 2017). (See Appendix A for illustration) 
 
Plyometric Push-up 
The purpose of the plyometric push-up was to assess impulse and rate of force 
development. This test determines how much upper extremity force one can produce 
and how fast the individual can produce it. While only a preliminary piece of literature 
exists, giving evidence on improved power output (Ziegenfuss et al., 2008) following A-
GPC ingestion. Another study (Bellar et al., 2015) found no evidence to support upper 
body power output post A-GPC consumption. Therefore, this investigation hopes to 
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shed new light on these contradictive findings following A-GPC ingestion on upper 
body power output. (See Appendix A for execution during the plyometric push-up). 
 
Reaction-time Test 
Reaction-time test using PsychoPy-Psychology software for Python (V1.82) 
determined reaction time in participants. This is a computer-based reaction time test 
that allows for custom programming. It also has the ability to program multiple 
scenarios, preventing errors from participants memorizing patterns of other reaction-
based tests (Peirce, 2007). The purpose of this test, originally written by Peirce as a 
proof of concept – is that a high-level scripting language could generate experimental 
stimuli in real time. Previous literature indicated acute ingestion of a supplement 
containing A-GPC can prevent induced-decline of reaction time in healthy college 
student’s following exhaustive exercise (Hoffman et al., 2010). However, limited 
studies exist examining reaction time following A-GPC ingestion and more research is 
needed to support the current evidence. (See Appendix A for figures of the reaction-
test). 
 
Summary 
This examination explores the influence of A-GPC in various anaerobic 
paradigms with particular attention given to the impact on performance variables. 
While there are lots of promise regarding A-GPC as a supplement to boost physical and 
mental performance, there is currently not enough literature examining A-GPC to 
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make this conclusion. Therefore, this study aims to fill the gap in the literature, in 
regard to A-GPC as a power output and cognitive supplement for college-aged 
individuals. The purpose of this investigation was to identify the acute effects of A-GPC 
in testing to placebo ingestion on jump height, hang-grip strength, power output, 
mood change, and reaction time in recreationally (moderately) trained, college-aged 
athletes. The author of this investigation predicts A-GPC ingestion will improve 
physical task performance on the aforementioned variables, benefiting cognitive 
function and power output. Currently only one piece of literature examines the acute 
effects A-GPC ingestion has on power output, where the population was men (30.1 ± 
7y) with two years of training experience (Ziegenfuss et al., 2008). Therefore, this 
research investigation was designed in efforts to bridge the gap in the current dearth 
of literature, in hopes to shed new light on A-GPC as a power output supplement one 
can use as an ergogenic aid to enhance strength via anaerobic paradigms, as well as 
stimulate cognitive facilitation, improving mood and reaction time in young healthy 
moderately trained adults. 
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CHAPTER III 
METHODOLOGY 
 
Inclusion/Exclusion 
The following inclusion criteria was established: College aged (18-26), 
recreationally (moderately) trained, healthy volunteer (resting BP under 140/90 
mmHg, resting HR < 100 bpm). According to the American College of Sports Medicine 
(Thompson et al., 2010), moderate training includes aerobic activity performed for a 
minimum of 30-min five times a week. Health history was assessed using a 
standardized university form to ensure that all applicants met the current standards 
and regulations of being a healthy participant in order to participate in the trials. 
Subjects were excluded from the study if the individual was untrained in recreational 
related activities (did not meet the aforementioned requirements of being 
recreationally trained); unhealthy (did not meet aforementioned requirements of 
being a healthy volunteer); or had a resting BP over 140/90 mmHg and/or a resting HR 
< 100 bpm. 
This research project took place in a university exercise physiology lab, where 
35 subjects were recruited to participate in the study. Twenty-seven subjects 
completed all three visits looking at the acute effects of A-GPC on performance 
enhancement.   
Prospective participants were recruited via recruitment letters and emails sent 
by the primary investigator. The cover letter and email briefly explained information 
17 
about how the participant was identified to receive the letter; who was responsible for 
conducting the study and why; the study procedures; overview of any risks or potential 
benefits; contact information; and proper notification about the confidentiality issues 
associated with email communication. 
 
Research Procedures 
Study Design. The study utilized a random, double-blinded, cross over design 
where subjects reported to the laboratory on three different occasions with each visit 
separated by 2-14 days. All subjects read and signed the informed consent application 
prior the initial familiarization trial, which included instructions on how to complete a 
24-hour food log, height and weight measurements, body plethysmography via BOD 
POD (Cosmed, USA), mood questionnaire, reaction time test, hand-grip strength, 
standing vertical jump, and the plyometric push-ups. Upon arrival to the testing facility 
and completion of informed consent procedures, subjects performed a brief 
standardized dynamic warm-up in preparation for physical activity.  
Following the dynamic warm-up, subjects were directed through the 
performance testing protocol where stations were structured in the following order; 
mood questionnaire, reaction-time test, hand-grip strength, standing vertical jump, 
and plyometric push-up (See Table 2 for procedure outline, Figure 2 for schematic of 
stations and Appendix 1 for descriptions of each maneuver).  
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Table 2: Procedure Outline 
Baseline Visit Placebo Visit A-GPC Visit 
Height Ingestion Ingestion 
Mood Questionnaire/ 
Reaction-Time Test-PRE 
Mood Questionnaire-PRE  Mood Questionnaire-PRE 
Blood Pressure/ Heart Rate/ 
Body Composition 
Reaction-Time Test-PRE Reaction-Time Test-PRE 
Reaction-Time Test-PRE Body Composition/ Heart 
Rate/ Blood Pressure 
Body Composition/ Heart 
Rate/ Blood Pressure 
Hand-Grip Strength Hand-Grip Strength Hand-Grip Strength  
Warm-Up Warm-Up Warm-Up 
Standing Vertical Jump Standing Vertical Jump Standing Vertical Jump 
Plyometric Push-Ups Plyometric Push-Ups Plyometric Push-Ups 
Mood Questionnaire-POST Mood Questionnaire-POST Mood Questionnaire-POST 
Reaction-Time Test-POST Reaction-Time Test-POST Reaction-Time Test-POST 
 
The subjects and research assistants who supervised the stations of the test 
were blind to the treatment. Subsequent testing sessions included the same 
procedures; the only difference was subject randomization into one of two groups 
prior to completing the testing stations. Group 1 (placebo trial) was required to 
consume (Dextrose); Group 2 consumed 6 mg·kgˉ¹ (A-GPC group). All test subjects 
were instructed to refrain from consuming food; caloric beverage and A-GPC 
substances at least 8 hours prior to each trial; and instructed to come in on a fasted 
state during testing days. Understanding nutrient-nutrient interaction between A-GPC 
combined with either uridine, iron, or caffeine may potentially skew the results 
(Troesch et al., 2009; Armah et al., 2008; Agarwal et al., 2018; Silveri et al., 2008). 
Therefore, the participants were asked to come in on a fasted state before treatment 
trials (visits 2 &3). Coming in on a fasted state requires the participants not consume 
anything eight hours prior to supplement ingestion on the treatment trials, preventing 
any possible unknown health-related risk or nutrient interaction that may exist. 
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Subjects were asked to continue current training throughout the duration of the study. 
However, subjects were instructed to abstain from hard training (exerting maximal 
effort to exhaustion) for 24 hours prior to each visit. Similar to baseline testing, the 
subjects completed blood pressure measurements, heart rate, mood questionnaire, 
and reaction-time testing each visit. At the end of the third and final session, data 
analysis compared the effects of the nutrient on physical task performance. Each trial 
was administrated, conducted, and separated by 2-14 days.  
 
Testing Procedure 
Baseline/Familiarization (Pre-Treatment). Subjects underwent a baseline trial 
during their first visit to the laboratory where subjects submitted a completed 24-hour 
food log that listed all foods and beverages the subject consumed in the previous 24-
hours. This was used to replicate caloric and macronutrient intake for the 24-hours 
prior to future trials. Subjects then completed baseline assessments for height, weight, 
blood pressure, and heart rate, followed by guidance through a standardized warm-up 
and completion of the aforementioned performance testing protocol.  Subjects were 
asked to come to the treatment visits in a fasted state and to abstain from hard 
training for 24-hours prior to performance testing. 
 
24-hour Food Log/Alpha-GPC Questionnaire/Health History 
Subjects were provided with a list of foods and beverages that contained A-GPC 
(See Appendix 3 for nutritional sources on A-GPC), and subjects were asked to refrain 
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from consuming these foods for 24-h before exercise testing. Subjects were provided 
with a 24-h food log before the first testing session, so each subject can replicate their 
diet before each of the following testing sessions. Subjects reported regular 
consumption of A-GPC via a questionnaire.  
 
Equipment 
Upon arriving to the laboratory, subjects first obtained baseline measurements 
for blood pressure and heart rate using a digital blood pressure cuff (Omron, USA), 
height was assessed using a tape measure from the base of the floor to the peak 
height of the individual (i.e. “wall height”), weight and body fat percentage was 
measured using body plethysmography via BOD POD (Cosmed, USA) following 
ingestion. The BOD POD is highly accurate and can detect even small changes in body 
fat and body mass (National Institute for Fitness & Sport, 2017). A digital blood 
pressure cuff was used to determine BP and HR, and PychoPy-Psychology software 
(Python, V1.82) was used to determine reaction time. The Just Jump Mat (Probotics, 
INC: Huntsville, AL) was used to assess force kinetics and jump height, the digital hand-
grip dynamometer (Takei Scientific Instruments, Japan) assessed overall strength while 
the force plates (Summit, INC) were used to determined peak force output and RFD 
during the vertical jump and plyometric push-ups. The force plate data was interfaced 
with a NI DAQ (national instruments) with custom written LabVIEW software (national 
instruments). 
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Treatment Protocol 
Supplementation Administration (Dosage). Prior to testing, on the second and 
third visits, subjects were randomly provided with a moderate dose of either A-GPC (6 
mg·kgˉ¹) or the same dosage of placebo (dextrose).  The samples were weighed and 
placed in a cup and mixed with 10 ounces of water, assigned in a randomized fashion. 
Test subjects consumed a different substance on each occasion, outside of the 
baseline trial where no substance was ingested. Subjects were instructed to sit in a 
rested state for 25-minutes following ingestion of either the supplement or placebo. 
The assigned supplement was prepared and delivered to the laboratory by a member 
of the research team outside of the testing facility.  Each sample was labeled with the 
subject’s name on a shaker bottle. These procedures were followed in order to 
maintain the double-blind procedure. During placebo visits, subjects ingested a dose of 
dextrose that was administered and calculated to increase plasma glucose 
concentrations by <0.3 mmol. L-1. These amounts have been utilized in previous 
literature and therefore were adopted for this current study (Anselme et al., 1992; 
Schneiker et al., 2006; Bell et al., 2001; Stuart et al., 2005; Astorino et al, 2010; Paton 
et al., 2010; Bellar et al., 2015; Stoppani, 2010; Ziegenfuss et al., 2008). The placebo 
consisted of dextrose, which was designed to mimic the actual supplement in terms of 
consistency for taste, texture, and color. 
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Warm-up Protocol 
Following the treatment protocol, prior to the testing battery, subjects were 
directed through standardized dynamic warm-up station, consisting of 10 body weight 
squats, and 10 push-ups, in preparation for physical activity. Subjects were assessed on 
hand-grip strength, jump height, rate of force development, power output, mood, and 
reaction-time.  
 
Testing Protocol 
 Following a 25-minute passive rest period following ingestion of the 
supplement or placebo, subjects performed a mood questionnaire. The mood 
questionnaire was completed post-ingestion, directly before each reaction-time test. 
The same researcher administered the questionnaires each time.  Body composition, 
blood pressure and heart rate measurements were then obtained. Subjects then 
completed the warm-up protocol and participated in the performance test. The test 
took place in the exercise physiology laboratory, designed with four stations assessing 
physical task performance, specifically measuring hand-grip strength, jump height, 
power output, mood, and reaction-time. (See Figure 2 for schematics of stations). 
23 
 
Figure 2: Schematics of Stations 
 
 The primary investigator and research team inspected the testing area prior 
and post each visit to ensure participant safety. Participants who noticed any 
unordinary discomfort during the duration of the performance testing were 
terminated from the study in order to limit any potential minimal risk. To help limit 
muscle soreness and body fatigue, participants were asked to refrain from high 
intensity exercise 24-hours leading up to each visit. Maximum efforts were taken to 
ensure participant safety, limiting any potential health-related risk. 
 
Reaction Time coding  
When analyzing the reaction time test, the column titles indicate the different 
combinations of manipulated variables. The first three letters indicate the flanker type. 
Flankers are the shapes that appear on the left and the right of the target participants 
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respond to. Con – congruent, which means the target is flanked by arrows that point 
the same direction, like this <<<<< and this >>>>>. Inc – incongruent, which means the 
target is flanked by arrows that point in the opposite direction, like this <<><< and like 
this >><>>. The fourth through sixth letters indicate the cue type. The cue is what 
appears right before the target and flankers. Val – Valid Cue, which means that the cue 
appears at the same location as the target (above or below the central fixation cross). 
Ori – Orienting Cue, which means that the cue appears at the center of the screen, but 
does not indicate the location of the target. It just alerts the participant that the target 
is about to appear. Non – No cue appears. The last letters indicate the dependent 
variable. RT – response time, which is reported in seconds, and only includes trials with 
accurate responses. Acc – proportion accurate. For example: ConValRT – congruent 
flankers, valid cue, Response time; ConOriRT –congruent flankers, orienting cue, 
Response time; ConNonRT – congruent flankers, no cue, response time; incValRT - 
incongruent flankers, valid cue, Response time; incOriRT - incongruent flankers, 
orienting cue, Response time; incNonRT - incongruent flankers, no cue, response time 
and so forth. 
 
Statistical Analysis 
A statistical power analysis was performed prior to testing to determine the 
adequate number of subjects needed to find a 10% difference in task performance 
between the placebo and A-GPC ingestion. Using a beta level of 0.80 was used to 
determine the probability of accepting the null hypothesis when it is false and an alpha 
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level of 0.05 determined the probability of rejecting the null hypothesis when it is true, 
and sample size was determined to be 11 subjects per group. Inter-rater reliability was 
established for the assessment of HR, BP, and hand-grip strength. Utilizing a 2-way 
mixed effect model and a consistency of agreement design (3, k), (ICC) intra-class 
correlations coefficients were determined to be between .80-.98 for the metrics. 
This investigation ran statistics on the continuous variables to determine mean 
and standard deviation and frequencies and percentages for categorical variables. 
Normality was examined using a Shapiro-Wilk test, which indicated the study variables 
were not normally distributed (p≤0.05). Non-parametric Mann-Whitney-U rank sum 
tests were performed to determine if a difference existed between pre and post 
testing for the following variables (mood change, reaction-time test, hand-grip 
strength, and jump height, upper and lower body rate of force development and peak 
force production).  Finally, in order to assess differences between the two 
supplementation options and the study variables, a repeated measures analysis of 
variance (RMANOVA) was performed. Multiple comparisons were assessed in a post-
hoc fashion using a least squared difference (LSD) procedure. Analyses were 
performed using a using SPSS software (Version 24, IBM, Armonk, New York). The level 
of significance was set at p< 0.05 for all comparisons.  Data was normalized to baseline 
results, change scores represented the difference between the supplementation trial 
in comparison to the baseline. 
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CHAPTER IV 
RESULTS 
 
Descriptive Statistics 
 Twenty-seven total subjects (m=15; f=12) participated in this study (Age: mean 
21.66 ±SD 1.88 years; Height: mean 68.4 ±SD 4.1 inches; Weight: mean 169. 02 ±SD 
32.2 lbs.; Body fat: mean 19.2 ±SD 8.8%; Heart rate: mean 67.96 ±SD 8.2 beats/minute; 
SBP: 120.59±SD12.39 mmHg; DBP 74.74±SD 9.12 mmHg). Frequency and percentages 
found 56% (m=15) of the participants in the study were males, and 44% (f=12) of the 
subjects who completed the study were females. (See Table 3 for mean difference and 
standard deviation results for demographics of the study). 
 
Table 3: Descriptive Statistics 
 Age HT BM Bfperc SBP DBP 
Mean 21.667 68.380 169.022 19.233 120.593 74.741 
SD 1.881 4.106 32.226 8.796 12.395 9.121 
Range 8 15 109.6 32.8 48 35 
Minimum 19 60 109.8 7.9 92 55 
Maximum 27 75 219 40.7 140 90 
Count 27 27 27 27 27 27 
 
There were no statistically significant differences between any of the variables 
pre to post testing. There were also no significant differences between males and 
females for any test variable.  
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Repeated measures ANOVA: Multiple comparisons, LSD 
Results revealed statistical differences for the following dependent variables of 
this study: fatigue, plyometric push-up peak force production, mood change, and 
accuracy during the reaction-time test. When examining fatigue during the mood 
questionnaire, the placebo and A-GPC groups reported lower levels of fatigue 
compared to baseline (0.719 points, p ≤ 0.019). Peak force production during the 
plyometric push-up was significantly greater (12% p ≤ 0.014) for A-GPC versus placebo 
(Table 4). Subjects reported being in a better mood during the A-GPC group compared 
to the placebo with a mean difference of 0.667 points (p ≤ 0.023) When looking at 
accuracy on the reaction-time test, subjects scored with less incorrect answers with A-
GPC ingestion when compared to placebo (12%, p ≤ 0.014).   
 
Table 4: Dependent Variables 
Dependent 
Variable 
A-GPC 
Treatment 
Compared 
To: 
Mean 
Difference 
Significance 
(P Value) 
95% 
Confidence 
Interval Level 
(Lower Bound) 
95% 
Confidence 
Interval Level 
(Upper Bound) 
Fatigue Baseline -0.719 
points 
0.019 -1.314 -0.123 
PP Peak Placebo  -12% 0.014 -22% -2.5% 
Mood 
Change 
Placebo 0.667 
points 
0.023 0.092 1.241 
RT-Test 
Accuracy 
Placebo -12% 0.014 -22% -2.5% 
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CHAPTER V 
DISCUSSION 
 
Summary 
The author of this investigation hypothesized that A-GPC would have positive 
acute effects on the performance variables of this study, improving physical task 
performance in college-aged recreationally trained athletes. When focusing on A-GPC 
consumption, subjects reported lower levels of fatigue and positive change in mood on 
the mood questionnaire post ingestion; increased force production during the plyometric 
push-up and participants had less incorrect answers when receiving the A-GPC 
supplement.  These findings illustrate young healthy adults may benefit from A-GPC 
ingestion if one is feeling fatigued, or before exercise (mentally or physically). 
A-GPC may influence fatigue in athletes, by preventing exercise-induced 
reductions in choline levels, increases endurance performance and growth hormone 
secretion (Parker et al., 2015). One study reported a multi-ingredient supplement that 
contained A-GPC during a maximal effort sprint test on a non-motorized treadmill but 
did not find any changes in counter-movement performance peak or mean power 
(Jagim et al., 2016). The current study demonstrated less fatigue occurred with A-GPC 
ingestion, which is in line with these previous investigations. However, the fatigue was 
reported by the subject in a qualitative manner and was not physiologically measured.  
Therefore, this finding should be interpreted with caution until physiologic verification 
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of less fatigue can be investigated. This evidence is in agreement with previous 
literature (Hoffman et al., 2010), but more physiological evidence is needed. 
While participants in this investigation reported feeling in a better mood 
following A-GPC ingestion, one previous study reported no changes in mood after A-
GPC supplementation (Parker et al., 2015).  It should be noted that although a 
significant difference was found between supplement ingestion and mood, the 
difference was less than 1 point on the Likert scale suggesting the mood improvement 
may not be clinically meaningful. 
A-GPC has been identified as a nutrient for the brain, otherwise known as a 
nootropic. Previous literature supports this supplement for cognitive function and 
mood enhancement (Hoffman et al., 2010), which would partially explain the 
improvement in accuracy on the reaction-time test (12% increase in accuracy) and the 
change in mood when subjects ingested A-GPC compared to the baseline in this study. 
One previous investigation supports the results of this study indicating acute ingestion 
of A-GPC can maintain reaction time, feelings of focus, alertness to both visual and 
auditory stimuli following high-intensity bouts of exercise (Hoffman et al., 2010). 
A-GPC ingestion yielded greater power output, creating more force production 
(12% increase) during the plyometric push-up movement compared to baseline, 
providing evidence that A-GPC may have ergogenic effects during upper body power 
output. However, no lower body benefits were found during the vertical jump or hand-
grip strength test when compared to placebo or baseline trials.  Previous literature 
supports this evidence where one study found supplementation of A-GPC increased 
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upper body power output by 14% (Ziegenfuss et al., 2008). While another investigation 
supports lower body force production following acute A-GPC supplementation, 
however, the same study found no improvements in upper body force production 
(Bellar et al., 2015). These contradictive findings could be due to inter-individual 
variability between differences in sample, responder’s vs non-responders etc. 
However, more research is needed to determine the physical and cognitive benefits of 
A-GPC 
 
Future research in this area 
Although this study supports A-GPC as an ergogenic aid, providing additional 
evidence to contradictive literature on force production, more research is needed. This 
investigation was the first to examine the acute effects A-GPC ingestion has on 
cognitive facilitation (reaction-time test and mood questionnaire) and power output 
(Hand-grip strength, standing vertical jump, and plyometric push-up) via anaerobic 
paradigms in young healthy adults. A future study may focus on examining a collegiate 
athletic program and the athletes by position to limit individual variability between 
subjects. Although previous studies support the evidence found in this investigation, 
further research is needed on this topic to clarify the benefits of A-GPC ingestion on 
physical and mental performance in young healthy adults. Ziegenfuss and colleagues 
(2008), noted, “Future work should examine how resistance exercise + A-GPC affect 
the growth hormone-insulin growth factor axis and their associated family of binding 
proteins” (p. 15). There is recent literature claiming citicoline and caffeine have a 
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theoretical synergistic effect, although there is no evidence currently (Bruce et al, 
2014), with A-GPC being a more potent form of choline, future research may want to 
examine this synergist effect that could potentially exist between A-GPC and caffeine. 
More research is needed to determine interactions between other nutrients such as 
uridine (Agarwal et al., 2018; Silveri et al., 2008) and iron (Armah et al., 2008; Troesch 
et al., 2009). 
 
Conclusion 
This study provides support, similar to previous literature, that A-GPC maybe 
beneficial as a cognitive and power output supplement. Significance of the study 
reveals a 12% increase in power output during the plyometric push-up and accuracy 
during the reaction-time test. This study sheds new light on the potential benefits A-
GPC may have on young healthy adults and the ergogenic effects of A-GPC. 
Specifically, A-GPC may improve trained college-aged individuals’ level of fatigue, 
mood, force production, and reaction time. For college students, the amount of time 
spent working and attending school may create challenges with expending and 
managing energy requirements. A-GPC could potentially serve as a reasonable 
supplement for young healthy adults attempting to deal with the stressors of everyday 
life or for the student looking for an advantage academically or with physical activity. 
Although future research is needed to give merit to these findings, A-GPC looks 
promising in supplementation as an ergogenic aid or to help facilitate cognitive 
function, promoting learning via enhanced memory recall.  
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DESCRIPTION OF STATIONS 
 
1. Hand Grip Strength  
The purpose of this test is to measure the maximum isometric strength of the 
hand and forearm muscles. Handgrip strength is important for any sport in 
which the hands are used for catching, throwing or lifting. Also, as a general 
rule people with strong hands tend to be strong elsewhere, so this test is 
often used as a general test of strength. A handgrip dynamometer is needed 
to perform this assessment. Following procedure: The subject holds the 
dynamometer in the hand to be tested, with the arm at right angles and the 
elbow by the side of the body. The handle of the dynamometer is adjusted if 
required - the base should rest on first metacarpal (heel of palm), while the 
handle should rest on middle of four fingers. When ready the subject 
squeezes the dynamometer with maximum isometric effort, which is 
maintained for about 5 seconds. No other body movement is allowed. The 
subject should be strongly encouraged to give a maximum effort. The 
position of the arm and hand can vary in different grip strength protocols. 
Various positions include the elbow being held at right angles as per the 
above procedure, the arm hanging by the side, and the extended arm being 
swung from above the head to by the side during the squeezing motion. 
The Eurofit Test Manual recommends squeezing for 3 seconds. The 
procedure for the Groningen Elderly Tests has the subject hang their hand by 
their side, one practice trial, best of three attempts with 30 seconds rest 
between. Scoring, the best result from several trials for each hand is 
recorded, with at least 15 seconds recovery between each effort.  
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2. Standing Vertical Jump Test 
(To assess average force on jumps and peak jump performance) 
Vertical jump will be recorded using the Just Jump or Run mat. Participants 
were instructed to jump and reach their maximum height. Just Jump or Run 
mat is measured in units of 0.1 inches. Participants will not be allowed to 
have a moving start. Each participant was given three attempts at the Just 
Jump or Run mat. The purpose of this test is to measure the leg muscle 
power. Equipment needed will be the jump mat. Procedure: Vertical jump 
height can be measured using a jump mat, which measures the 
displacement of the hips. To be accurate, you must ensure the feet land 
back on the mat with legs nearly fully extended. The vertical jump is usually 
performed with a countermovement, where there is bending of the knees 
immediately prior to the jump. Scoring: the jump height will be recorded as 
a distance score (possible conversions for jump height into a power or work 
score may be calculated).  
 
 
 
3. Plyometric Push-up Test 
(To assess impulse and rate of force development) 
During the plyometric push-ups (otherwise known as clap push-ups), the 
participants will lower the chest, down toward the force plates, while 
maintaining a straight line with their body. After this phase, the subject 
would forcefully push up and while in the air clap their hands together (if 
possible) before landing back onto the force plates. One full repetition was 
defined as successfully completing both phases of the exercise and returning 
to the starting position after landing back onto the force plates (Koch et al., 
2012). The subjects will be instructed to perform each repetition 
consecutively with maximal explosiveness and no pause (rest) between 
repetitions. After the completion of the 4 repetitions of each set. The 
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standard modified push-up will be an alternative for subjects who cannot get 
full extension and separation from the force plates. 
 
 
4. Reaction-Time Test 
Reaction-time test will be conducted using PsychoPy-Pyschology software 
for Python V1.82. This is a computer based reaction time test that allows for 
custom programming. It also has the ability to program multiple scenarios, 
preventing errors from participants memorizing patterns of other reaction 
based tests (Peirce, 2007). In 2003, PsychoPy was originally written by Peirce 
as a proof of concept - that a high-level scripting language could generate 
experimental stimuli in real time. Reaction-time will be assessed prior 
ingestion and post-test, directly before each mood test. Each subject will 
have a letter on the keyboard designated for left and right arrows which will 
appear on the computer screen, with the index finger on each hand pressing 
the key that represents the arrow as soon as the subject specifies the 
direction of the arrow. Reaction-time test will be employed following the 
mood questionnaire, post-ingestion, pre and post-test.  
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FOOD SOURCES OF A-GPC 
 Toasted wheat germ (33.78mg/100g), wheat crackers (10.94mg/100g), and 
wheat bread (4.93mg/100g) 
 
 Oat bran (33.25mg/100g) 
 2% Milk (9.98mg/100g) and skim milk (9.70mg/100g) 
 Cheese (2.30mg/100g), Cottage cheese (8.39mg/100g), Cream cheese 
(9.26mg/100g) 
 Yogurt (7.79-9.10mg/100g) 
 Eggs (0.60mg/100g) 
 Chicken breast (1.12-1.20mg/100g) and liver (8.80mg/100g) 
 Pork sausage (7.41mg/100g), cooked pork loin (22.51mg/100g) 
 Beef liver (77.93mg/100g) 
 Atlantic cod (30.04mg/100g), Salmon (5.89mg/100g) 
 Bananas (5.60mg/100g), blueberries (0.61mg/100g), avocado (0.73mg/100g), 
grapefruit (1.16mg/100g), cantaloupe (0.71mg/100g), oranges (1.10mg/100g), 
and strawberries (0.86mg/100g) 
 Broccoli (1.32mg/100g), cabbage (3.47mg/100g), cucumber (0.48mg/100g), 
spinach (0.21mg/100g), onions (0.57mg/100g), sauerkraut (0.94mg/100g), 
sweet potatoes (1.97mg/100g), Russel sprouts (3.18mg/100g), and raw 
mushrooms (5.11mg/100g) 
 Beer (light at 2.98mg/100g, regular at 5.06mg/100g) and coffee (0.67mg/100g) 
Steven H. Zeisel2, Mei-Heng Mar, Juliette C. Howe*, and Joanne M. Holden (2003) The 
American Society for Nutritional SciencesConcentrations of Choline Containing 
Compounds and Betaine in Common Foods. 
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Recruitment Letter 
The Acute Effects of Alpha-GPC on Hand 
Grip Strength, Jump Height, Rate of Force 
Development, and Reaction-Time in 
Recreationally Trained, College-Aged 
Athletes  
Researcher:  Josey Lucas Cruse  
College of Health Sciences 
Department of Exercise and Sports Science at Eastern Kentucky University  
Josey_cruse10@mymail.eku.edu 
859-302-4443 
  
  Dear Potential Participant, 
 
   You are being invited to participate in a research study to examine the 
ergogenic effect of strength and power training supplement, A-GPC, during physical 
task performance. A-GPC is a supplement that has previously been researched and 
proven to increase levels of acetylcholine in the blood and growth hormone secretion. 
Increased levels of acetylcholine in the body have been shown to enhance strength 
and explosive ability (power). Elevated levels of GH in the body have also been shown 
to increase strength and explosive ability. Few studies have examined the effect of A-
GPC on sport performance. Therefore, your participation in this investigation hopes to 
further the research literature on this topic, aiming to identify the acute effects of A-
GPC ingestion on Hand Grip Strength, Jump Height, Rate of Force Development, and 
Reaction-Time in Recreationally Trained, College-Aged Athletes  
  For this study you will be asked to report to the exercise physiology lab in the 
Moberly facility, on 3 separate occasions, separated by 2-7 days. You will be asked to 
come at the same time for each testing. You will be provided with a list of foods and 
beverages that contain A-GPC and asked to refrain from these foods. You will be asked 
to abstain from hard training for at least 24 hours prior to each visit. Before and after 
each visit you will be asked to perform a reaction-time test conducted using PsychoPy-
Pyschology software (Python V1. 82.). Next, measurements for blood pressure, heart 
rate, height and weight will be assessed, and body fat percentage will be determined 
using the BOD POD.    
  After that, you will be asked to perform a series of physical performance tests 
(4 stations, consisting of the hand grip strength, standing vertical jump, plyometric 
push-ups, and reaction-time). First, you will perform the reaction-time test before 
physical performance. Next you will be tested on hand grip strength using a dyno-
meter, followed by the standing vertical jump test in which you will be asked to jump 
as high as you can to test your lower body explosive ability will be assessed using the 
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jump mat. Next, you will perform the plyometric push-ups on the force plate to assess 
impulse and rate of force development. 
Prior to testing, on the second and third visit, you will randomly be provided with a 
moderate dose of either alpha-GPC (6 mg·kgˉ¹) or the same dosage of placebo 
(dextrose), which will be weighed and placed in a cup and mixed with 10 ounces of 
water and assigned in a randomized fashion. You will consume a different substance 
on visit two and three, outside the baseline trial, where no substance will be ingested. 
Subjects will be instructed to sit in a rested state for 45 minutes following ingestion of 
either the supplement or placebo. The assigned supplement was prepared by an 
outside member of the research staff and delivered to the laboratory with the 
subject’s name on a shaker bottle in order to maintain a double-blind procedure. 
  If you chose to start this study, you should be aware that you will receive no 
benefits such as extra credit or course credit in any College of Health Sciences course. 
You may choose to stop the study at any time and will face no penalty.  Your 
participation is completely voluntary. The study will take approximately 5 hours of 
your time over the course of 15 days, and you may experience some muscle soreness 
as a result of the exercise.   
  The intention is to analyze the data after the study is complete and make a 
report and publish in a scientific journal. Your name will not be part of any reporting of 
any information from this study. The files from the study will be stored in an encrypted 
file, on a password protected computer accessible only to Dr. Lane. If you have any 
questions about this study, please contact either Josey Cruse at 
josey_cruse10@mymail.eku.edu or Dr. Michael Lane at Michael.lane@eku.edu. 
Respectfully, 
 
Josey Cruse 
 
 
 
 
 
 
 
 
 
